Neogen Chemicals
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Neogen Chemicals has reported a strong start to FY27, with record revenues in its Organolithium and Battery Chemicals segments, driven by strategic investments in capacity expansion. Management's focus on the battery materials value chain, supported by potential Production-Linked Incentive (PLI) schemes, positions the company favorably within the emerging domestic battery ecosystem. This aligns with Vista's forecast of accelerating revenue growth and improving margins, as the company capitalizes on robust demand in specialty chemicals. However, execution risks remain, particularly in stabilizing new facilities and achieving high utilization rates among domestic cell OEMs, which could impact profitability. The current macro environment in India, while showing positive growth signals, presents challenges with tightening liquidity and inflation concerns. Over the next 12-24 months, key opportunities include the expansion of battery chemical production and potential market share gains, while headwinds may arise from competitive pricing pressures and the need for effective capital allocation. Overall, Neogen's strategic initiatives and market positioning support Vista's outlook of fair valuation with modest expected upside
Why We Like This Stock
- Record revenues in Organolithium and Battery Chemicals segments indicate strong demand and growth potential
- Strategic investments in capacity expansion align with the emerging domestic battery ecosystem and potential PLI support
- Management's optimistic outlook and upward revision of revenue guidance reflect confidence in future performance
Things To Watch Out For
- Execution risks related to stabilizing new facilities could hinder profitability and growth
- Tightening liquidity and inflation concerns in the macro environment may impact market sentiment
- Competitive pricing pressures in the specialty chemicals sector could challenge margin expansion
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 691 | 778 | 862 | 986 | 1,312 |
| Profit Before Tax (Cr.) | 53 | 64 | 41 | 62 | 84 |
| PBT Margin | 7.7% | 8.2% | 475.6% | 6.2% | 6.4% |
| Net Profit (Cr.) | 41 | 38 | 23 | 46 | 63 |
| Earnings Per Share | 14.9 | 14.0 | 8.4 | 16.9 | 23.1 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| IDBI Capital | ▲ Buy | 2,501 | 29-Jul-2026 |
| Kotak Securities | ► Add | 2,190 | 28-Jul-2026 |
Company Overview
Show Company Profile
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, specialty polymers, vapor absorption chillers, emerging battery material applications, and other industries. The company also exports its products to 33 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.